Preclinical and Clinical Characteristics of Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor - Laux, Volker; Perzborn, Elisabeth; Kubitza, Dagmar; Misselwitz, Frank (Seminars in Thrombosis and Hemostasis, 2007)